Shunsuke Itai

1.2k citations
52 papers · 924 indexed · h-index 17
Topics
Lymphatic System and Diseases (27 papers)Lymphatic Disorders and Treatments (22 papers)Glycosylation and Glycoproteins Research (14 papers)
Partner nations
Japan

In The Last Decade

Shunsuke Itai

51 papers receiving 924 citations

Peers

Shunsuke Itai
Comparison fields: 5 of 41
  • Oncology 723
  • Molecular Biology 359
  • Surgery 318
  • Immunology 308
  • Radiology, Nuclear Medicine and Imaging 241
Replace Yuki Fujii with:
Yuki Fujii Japan
Takaaki Yasuhara Japan
Merel Gijsen United Kingdom
Roelof J.C. Kluin Netherlands
Pamela A. Davol United States
Carmine Fedele United States
Ik Sun Kim United States
Ioannis Roxanis United Kingdom
Giovanni Francesco Castino Italy
Sihem Khelifa United States
Shunsuke Itai relative to Yuki Fujii Japan Yuki Fujii's profile →
Citations per field
00.5×3.7×
Yuki Fujii · 1×
Citations per year

Countries citing papers authored by Shunsuke Itai

Since Specialization
Citations

This map shows the geographic impact of Shunsuke Itai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shunsuke Itai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shunsuke Itai more than expected).

Fields of papers citing papers by Shunsuke Itai

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shunsuke Itai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shunsuke Itai. The network helps show where Shunsuke Itai may publish in the future.

Co-authorship network of co-authors of Shunsuke Itai

This figure shows the co-authorship network connecting the top 25 collaborators of Shunsuke Itai. A scholar is included among the top collaborators of Shunsuke Itai based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shunsuke Itai. Shunsuke Itai is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 8
2 42
3 12
4 9
5 13
6 6
7 11
8 4
9 17
10 45
11 5
12 4
13 8
14 17
15 8
16 12
17 16
18 59
19 9
20 6

About Shunsuke Itai

Shunsuke Itai is a scholar working on Oncology, Immunology and Equine, having authored 52 papers that have together received 924 indexed citations. Recurring topics across this work include Lymphatic System and Diseases (27 papers), Lymphatic Disorders and Treatments (22 papers) and Glycosylation and Glycoproteins Research (14 papers). The work is most often cited by research in Oncology (723 citations), Immunology (308 citations) and Radiology, Nuclear Medicine and Imaging (241 citations). Shunsuke Itai has collaborated with scholars based in Japan. Frequent co-authors include Mika K. Kaneko, Yukinari Kato, Shinji Yamada, Takuro Nakamura, Hiroyuki Harada, Miyuki Yanaka, Yoshikazu Furusawa, Masato Sano, Masato Fukui and Yao‐Wen Chang. Their work appears in journals such as Oncotarget, Heliyon and Biochemistry and Biophysics Reports.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026